HIV and pregnancy

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 12, 1996, Pages 1184-1190

  Johnstone, Frank D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ZIDOVUDINE;

BREAST FEEDING; CESAREAN SECTION; DRUG EFFICACY; FEMALE; FETUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREGNANCY; PRIORITY JOURNAL; REVIEW; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

CESAREAN SECTION; FEMALE; HIV INFECTIONS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL DIAGNOSIS; WORLD HEALTH; ZIDOVUDINE;

EID: 0029842621     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09626.x     Document Type: Review

References (81)

1. Verkuyl DAA. Practising obstetrics and gynaecology in areas with a high prevalence ofHIV infection. Lancet 1995;346:293–296.
2. WHO. The World HeaIth Report 1995–Bridging the Gaps. Geneva: World Health Organization, 1995:22.
3. WHO. The World Health Report 1995–Bridging the Gaps. Geneva: World Health Organization, 1995:13.
4. Grosskurth H, Mosha F, Todd J et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in nual Tanzania: randomised controlled trial. Lancet 1995; 346: 530–536.
5. Lindan C, Allen S, Serufilira A et al. Predictors of mortality among HIV infected women in Kigali, Rwanda. Am Intern Med 1992; 116: 321–328.
6. Confidential, Enqujr. Report on Confidential Enquiries into Maternal Deaths in the Unrted Kingdom 1991–1993. London: HMSO, 1996.
7. Ho DD, Neumann AV, Perelson AS, Chen W, Leonard JM, Markovita M. Rapid turnover of plasma virions and CD, lymphocytes in HIV-1 infection. Nature 1995; 373:123–126.
8. Wei X, Ghosh SK, Taylor ME et al. Viral dynamics in human immune odeficiency virus type 1 infection. Nature 1995; 373:117–122.
9. Wain, Hobson C. The fastest genome evolution ever described: HIV variation in situ. Current Opin GenetDis 1993; 3: 878–883.
10. Feinberg IKB. Changing the natural history of HIV disease. Lancet 1996; 348:239–246.
11. Claici M, Shearer GM. The Thl-Th2 hypothesis of HIV infection: new insights. Immunology Today 1994; 15: 575–581.
12. Roederer M. T-cell dynamics of immunodeficiency. Nature Medicine 1995; 1: 621–622.
13. Margolick JB, Munoz A, Donnenburg AD et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Medicine 1995; 1: 674–680.
14. Heeney JL. AIDS: a disease of impaired Th-cell renewal Immunol ogy Today 1995; 16:515–520.
15. Cao Y, Qin L, Zhang L et al. Virologic and immunologic characterisa tion of long-term survivors of human immunodeficiency virus type 1 infection. NEngIJMed 1995; 332: 201–208.
16. Pantaleo G, Memo S, Vaccarezza M et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995; 332:209–216.
17. Larder BA, Kellam P, Kemp SD. Zidowdine resistance predicted by direct detection of mutations in DNA from HlV-infected lympho cytes. AIDS 1991; 5: 137–144.
18. Larder BA, Kemp SD, Harrigan PR. Potential mechanism for sub stantial antiretroviral efficacy of AZT-3 TC combination therapy. Science 1995; 269: 696–699.
19. Eron JJ, Benoit SL, Jemsek J et al. Treatment with lamivudine, zidovudine or both in HIV-positive patients with 200–500 CD,+ cells per cubic millimetre. N Engl J Med 1995; 333: 1662–1669.
20. Montana JSG, Schechter MT. A year of transformation in HIV/AIDS. Lancet 1995; 346 Suppl: 12.
21. Ho DD. Time to hit HIV early and hard. N Engl J Med 1995; 333: 450–451.
22. Johnstone FD, Thong KJ, Bird AG et al. Lymphocyte subpopulations in early human pregnancy. Obstet Gynecol 1994; 83:941–946.
23. Brettle RP, Raab GM, Ross A et al. HIVinfection in women: immunological markers and the influence of pregnancy. AIDS 1995; 9: 1177–1184.
24. Hocke C, Morlat P, Chene G et al. and the Groupe d'Epidemologie Clinique des SIDA en Aquitaine. Prospective cohort study of the efect of pregnancy on the progression of human immunodeficiency virus infection. Obstet Gynecol 1995; 86: 886–891.
25. Johnstone FD, Willox L, Brettle RP. Survival time after AIDS in preg nancy. BrJObstet Gynaecol 1992; 99: 633–636.
26. Johnstone FD, MacCallum L, Brettle RP et al. Does infection with HIV affect the outcome of pregnancy BMJ 1988; 296:467.
27. Miotti PG, Dallabetta GA, Ndovi E et al. HIV-1 and pregnant women: associated factors, prevalence, estimate of incidence and role in fetal wastage in Central Africa. AIDS 1990; 4: 733–736.
28. Miotti PG, Dallabetta GA, Chiphangwi JD et al. A retrospective study of childhood mortality and spontaneous abortion in HIV-I infected women in urban Malawi. Int J Epidemiol 1992; 21:792–799.
29. Temmerman M, Lopita MI, Sanghui HCG et al. The role of maternal syphilis, gonorrhoea and HIV-1 infection in a spontaneous abortion. Int J STDAIDS 1992; 3:418–422.
30. Johnstone FD. Pregnancy outcome and pregnancy management in HIV-infected. In: Johnson MA, Johnstone FD, editors. HIV infection in women. Edinburgh: Churchill Livingstone, 1993:187–198.
31. Johnstone FD, Raab GM, Hamilton BA. The effect of human immune odeficiency virus infection on birth characteristics. Obstet Gynecol 1996;88:321–326.
32. Newell ML, Peckham CS. Risk factors for vertical transmission of HIV-1 and early markers of HIV-1 infection in children. AIDS 1993; 7 (Suppl 1): s91–s97.
33. Dickover RE, Garratty EM, Herman SA et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmis sion: effect of maternal zidovudine treatment on viral load. JAMA 1996; 275: 599–605.
34. Peckham C, Gibb D. Mother-to-child transmission of the immunode ficiency virus. N Engl J Med 1995; 333: 298–302.
35. Brossard Y, Aubin J-T, Mandelbrot L et al. Frequency of early in utero HIV-1 infection: a blind DNApolymerase chain reaction study in 100 fetal thymuses. AIDS 1995; 9:359–366.
36. Dunn DT, Newell ML, Aden AE, Peckham CS. Risk of human immunodefciency virus type 1 transmission through breast feeding. Lancet 1992; 340: 585–588.
37. Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live attenuated SIV after mucosal infection of neonatal macaques. Science 1995; 267: 1820–1825.
38. European Collaborative Study. Risk factors for mother-to-child trans mission of HIV-I. Lancet 1992; 339: 1007–1012.
39. Goedert JJ, Duliege AM, Amos CI, Felton S, Biggar RJ. High risk of HIV-I infection for first born twins. The International Registry of HlV-Exposed Twins. Lancet 1991; 338: 1471–1475.
40. Duliege A-M, Amos CI, Felton S, Biggar RJ, Goedert JJ. The interna tional registry of HIV-exposed twins. Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. J Paediatr 1995; 126: 625–632.
41. Landesman SH, Kalish LA, Burns DN, Hinkoff H, Fox HE, Zorilla C et al. Obstetrical factors and the transmission of human immunodefi ciency virus type 1 from mother to child. N Engl J Med 1996; 334: 1617–1623.
42. Ehmst A, Lindgren S, Dictor M et al. HIV in pregnant women and their offspring: Evidence for late transmission. Lancet 1991; 338: 203–207.
43. Krivine A, Firtion G, Cao L, Francoual C, Henrion R, Lebon P. HIV replication during the first weeks of life. Lancet 1992; 339: 1187–1189.
44. Dunn DT, Brandt CD, Krivine A et al. The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative con tributions of intra-uterine and intra partum transmission. AIDS 1995; 9:F7–Fll.
45. Simonon A, Lepage P, Karita E et al. An assessment of the timing of motha-toshild transmission of human immunodeficiency virus type 1 by means of polymerase chain reaction. AIDS 1994; 7: 952–957.
46. Rouzioux C, Costalagliola D, Burgard M, Blanche S, Mayaux MJ, Griselli C, Valleron AJ. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Marker model. The HIV infection in French Collaboration Group. Am JEpidemiol 1995; 142: 1330–1337.
47. Connor EM, Sperling RS, Gelber R et al. Reduction of matemal-infant transmission of human immunodefiency virus type-1 with zidovudine treatment. NEnglJMed 1994; 331: 1173–1180.
48. Newell ML, Gibb DM. A risk-benefit assessment of zidovudine in the prevention of perinatal HIV transmission. Drug Safety 1995; 12: 274–282.
49. Kumar RM, Hughes PF, Khurranna A. Zidovudine use in pregnancy: a report on 104 cases and the occurrence of birth defects. J AIDS Hum Retrovirol 1994; 7: 1034–1039.
50. Rouse DJ, Owen J, Goldenberg RL, Vennund SH. Zidovudine for the prevention of vertical HIV transmission: a decision analytic approach. J AIDS Hum Retrovirol 1995; 9:401–407.
51. Fiscus SA, Adimora AA, Schoenhach VJ, Lim W, McKinney R, Rupar D, Kenny J, Woods C, Wilfert C. Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties. JAM 1996; 275: 1483–1488.
52. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Luncei 1994, 343: 1464–1467.
53. Mayaux MJ, Blanche S, Rouxioux C et al. Maternal factors associ ated with perinatal HIV-1 transmission: The French Cohort Study: 7 years of follow-up observations (The French Pediatric HIV Infection Study Group). J AIDS Hum Retrovirol 1995; 8:188–194.
54. Dunn DT, Newell ML, Mayaux MJ et al. Mode of delivery and verti cal transmission of HIV-I: a review of prospective studies. AIDS 1994; 7:1064–1066.
55. Semprini AE, Catagra C, Rarizza M et al. The incidence of complica tions after caesarean section in HIV-positive women. AIDS 1995; 9: 913–917.
56. Towers CV, Deveikis A, Asrat T et al. Role of ‘bloodless caesarean section’ to decrease maternal child HIV transmission: a pilot study [abstract]. IXth International Conference on AIDS; Berlin; 1993. Abstract No. PO-C16 2978.
57. RCOG Working Party Report, 1996. In press.
58. WHOA/NICEF. Consensus statement from the WHO/UNICEF Consultation on HIV trasmission and breastfeeding. wkly Epidemiol Rec 1992; 67: 177–179.
59. Hamson MA, Hammer SM. Inactivation of human immunodeficiency virus by betadine products and chlorhexidine. AIDS 1989; 2: 16–20.
60. Biggar RJ, Miotti PG, Taha TE, Mtimavalye L, Broadhead R. Justesen, A et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347: 1647–1650.
61. Sherr L, Hodge B, Melvin D et al. Emotional trauma of HlV and AIDS for women. Counsel Psychol Q 1993: 6: 99.
62. Sherr L. Psychosocial aspects of providing care for women with HIV infection. In: Minkoff HL, de Hovitz JA, Duerr A, editors. HIV Infectionin Women. New York Raven Press Ltd 1995:107–123.
63. Holman S. HIV counselling for women of reproductive age. In: HIV infection in obstetrics and gynaecology. Bailieres Clin Obstet Gynaecol 1992; 6: 53–68.
64. Centres for Disease Control. US Public Health Service recommenda tions for human immunodeficiency virus counselling and voluntary testing for pregnant women. MMWR 1995; 44: 1–15.
65. Chrystie IL, Zander L, Tilzey A et al. Voluntary, named testing for HIV in a community based antenatal clinic: a pilot study. BMJ 1995; 311:928–931.
66. Holland FJ, Ades AE, Davison CF et al. Use of anonymous newborn serosurveys to evaluate antenatal HIV screening programmes. J Med Screen 1994; 1: 176–179.
67. Lindgren S, Bohlin A-B, Forsgren M et al. Screening for HIV-I anti bodies in pregnancy: results from the Swedish national programme. BMJ 1993 307: 1447–1451.
68. Chrystie IL, Zander L, Tilzey A et al. Is HIV testing in antenatal dinics worthwhile AIDS Care 1995;7: 135–142.
69. Boyd KM. HIV infection: the ethics of anonymised testing and of testing pregnant women. J Med Ethics 1990; 16: 173–178.
70. Goma R. Women Like Us. Positively Women, 1994.
71. Eickhoff TC. Hospital policies on HIV antibody testing. JAMA 1988; 259:1861–1862.
72. Wilfert CM. Mandatory screening of pregnant women for the human immunodeficiency virus. Clin Infect Dis 1994; 19: 664–666.
73. Touchette N. CDC and congress at odds over mandatory HIV testing. Nature Medicine 1995; 1: 723–724.
74. Smith JR, Forster GE, Kitchen VS et al. Infertility management in HIV positive couples: a dilemma. BMJ 1991; 302: 1447–1450.
75. Powers MJ, Hams NH. In: Medical Negligence. London: Butter-worths. 1990: 80.
76. Rothenburg KH, Paskey SJ. The risk of domestic violence and women with HIV infection: implications for partner notification, public policy and the law. Am J Public Health 1995; 85: 1569–1576.
77. Maintaining confidentiality [editorial]. Lancet 1995; 346: 1173.
78. Temmermann M, Ndinga-Achola J, Ambani J et al. The right not to know HIV–test results. Lancet 1995; 345: 969–970.
79. Culliton BJ. The greatest threat of all [editonal]. Nature Medicine 1995; 1: 1221.
80. Wilson ME. Infectious diseases: an ecological perspective. BMJ 1995 311: 1681–1684.
81. Decosas J, Kane F, Anarfi JK et al. Migration and AIDS. Lancet 1995; 346: 826–828.